Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology, 2020 FC 827 (Infliximab*)
Justice Phelan - 2020-08-17
Read full decision. Automatically generated summary:
The issue for resolution is whether the Reconsideration Hearing should be conducted in-person or by Zoom. ... This is a matter which, given its electronic record and limited scope, is readily Zoomable – it can be done but should it be done by Zoom? ... For many of the reasons advanced by the Plaintiff/Defendants by Counterclaim, I am of the view that the argument itself should be conducted in-person. It will facilitate communication with and between the Court and counsel and between counsel. However, this is also a situation where the proceeding may also benefit from the use of Zoom. By being a hybrid proceeding, clients, observers and interested persons can attend the hearing remotely. ... Therefore, argument on this matter scheduled for September 9, 2020, will proceed in Toronto with those counsel reasonably essential to the conduct of the argument present. In all other respects, the proceeding shall be conducted over Zoom.
Decision relates to:
- T-396-13 - HOSPIRA HEALTHCARE CORPORATION v. THE KENNEDY INSTITUTE OF RHEUMATOLOGY